HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Balcarova, J. Articles by Simons, K. Search for Related Content PubMed PubMed Citation Articles by Balcarova, J. Articles by Simons, K. Agricola Articles by Balcarova, J. Articles by Simons, K.

Antibody Response to Spike Protein Vaccines Prepared from Semliki Forest Virus

¹ Institut for Immunologie, Deutsches Krebsforschungszentrum, Heidelberg, F.R.G.
and² European Molecular Biology Laboratory, Postfach 10.2209, Heidelberg, F.R.G.

Subunit vaccines, containing the spike glycoproteins of Semliki Forest virus (SFV) in three different forms, have been prepared: detergent-solubilized monomers, detergent- and lipid-free octamers, and virosomes in which the spike proteins are reconstituted into phospholipid vesicles. Previous studies have shown that the octamers and the virosomes are very efficient in protecting mice against the encephalitis caused by virulent SFV (Morein et al., 1978). In this study we have characterized the specific antibody responses in mice vaccinated with the three SFV vaccines and correlated them with the protection against SFV encephalitis. The multimeric forms induced high humoral antibody titres; two doses of only 1 µg protein gave rise to specific antibody titres of 0.6 mg/ml. The monomeric form was much less immunogenic.

Received 28 July 1980; accepted 7 October 1980.